Cargando…
Rhabdomyolysis or Myositis following a SARS-CoV-2 Vaccination
Autores principales: | Finsterer, Josef, Scorza, Fulvio A., Almeida, Antonio-Carlos G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289857/ https://www.ncbi.nlm.nih.gov/pubmed/37362358 http://dx.doi.org/10.1055/s-0043-1764143 |
Ejemplares similares
-
SARS-CoV-2 associated rhabdomyolysis in 32 patients
por: FINSTERER, JOSEF, et al.
Publicado: (2021) -
Diagnosing SARS-CoV-2 vaccination-related rhabdomyolysis requires the exclusion of all differential causes
por: Finsterer, Josef, et al.
Publicado: (2023) -
Rule out appropriately all differentials before attributing severe rhabdomyolysis to SARS-CoV-2 vaccination
por: Finsterer, Josef, et al.
Publicado: (2022) -
Fatal SARS-CoV-2 Associated Rhabdomyolysis Requires Elucidation
por: Finsterer, Josef, et al.
Publicado: (2021) -
Spot the adenoma after pituitary apoplexy following a SARS-CoV-2 vaccination
por: Finsterer, Josef, et al.
Publicado: (2022)